In a study done by the Harvard Medical School and team it was seen that patients with multiple sclerosis when given albuterol, a medication used to treat respiratory diseases like asthma, they showed an enhanced neural response and the nerve cells improved in health. The study that was published in Archives of Neurology showed that after one year of treatment with a combination of albuterol and glatiramer acetate the patients responded well and showed improved health.

Multiple Sclerosis is a chronic inflammatory disease of the nerve cells where myelin a coating of nerve cells in the white matter of the central nervous system is degenerated. In MS a person's own immune system attacks the central nervous system. Eventually the patient loses the ability to function normally since the brain cannot send message to the central nervous system, paralysis sets in and finally death. However fighting this disease is quite tough.

Hence this finding brings hope to many. During the clinical trial involving 44 patients, those who received daily dose of Albuterol and glatiramer acetate showed improved response. The medication also seemed to delay the instances of relapse allowing the patient to lead a better life.